Rebecca Chambers
Net worth: 8 M $ as of 2026-07-30
Net worth: 8 M $ as of 2026-07-30
Rebecca Chambers is currently Chief Financial Officer at Veracyte, Inc. since 2021.
Former roles include Independent Director at Inari Medical, Inc. from 2021 to 2025, Chief Financial Officer at Outset Medical, Inc. from 2019 to 2021, Director-Investor Relations & Communications at Myriad Genetics, Inc. from 2011 to 2012, Senior Manager-Investor Relations at Life Technologies Corp.
from 2009 to 2010, Senior Research Associate at Millennium Pharmaceuticals, Inc. from 1999 to 2003, Vice President at Bank of America Corp., VP-Finance, Investor Relations & Treasury at Illumina, Inc., Director at Alamar Biosciences, Inc. Education includes undergraduate studies at John Carroll University and an MBA from Johnson Graduate School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERACYTE, INC. 0.22% | 2026-06-03 | 173,280 ( 0.22% ) | 8 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| VERACYTE, INC. | Director of Finance/CFO | 2021-07-18 |
| Companies | Position | End |
|---|---|---|
| INARI MEDICAL, INC. | Director/Board Member | 2025-02-18 |
| OUTSET MEDICAL, INC. | Director of Finance/CFO | 2021-07-15 |
| MYRIAD GENETICS, INC. | Investor Relations Contact | 2012-09-30 |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Public Communications Contact | 2010-11-30 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 2002-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Bank of America Corp.
Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Outset Medical, Inc.
Outset Medical, Inc. Medical SpecialtiesHealth Technology Operates as a pioneering medical technology company which develops and commercializes reimagining dialysis for patients & health care providers | Health Technology |
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. Medical SpecialtiesHealth Technology In vitro diagnostics | Health Technology |
John Carroll University
John Carroll University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Inari Medical, Inc.
Inari Medical, Inc. Medical SpecialtiesHealth Technology Develops catheter-based mechanical thrombectomy devices | Health Technology |
Select your edition
All financial news and data tailored to specific country editions